Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The Effect of Mild-gain Amplification on Tinnitus Perception in Normal Hearing Adults

NCT: NCT07489807 · RECRUITING

NCT IDNCT07489807
StatusRECRUITING
Start Date2025-04-01
Completion2027-06-01

Brief Summary

This study investigated the effect of mild gain amplification (8dB covering 1 Hz to 8kHz) as tinnitus treatment for participants with normal hearing and compared these effects with an active placebo condition using hearing aids without amplification in a double-blinded crossover study. 12 participants with normal hearing and chronic tinnitus were included in the study. Two different hearing aid treatments were provided for 3 weeks each: mild gain amplification that provided 8dB gain in the frequency range from 1 Hz to 8 kHz and no amplification, acting as placebo. The effect of the two treatments on tinnitus distress was evaluated with the Tinnitus Functional Index (TFI) questionnaire. The effect of the treatment on tinnitus loudness and annoyance were evaluated with a visual analog scale (VAS).

Frequently Asked Questions

What is The Effect of Mild-gain Amplification on Tinnitus Perception in Normal Hearing Adults?

The Effect of Mild-gain Amplification on Tinnitus Perception in Normal Hearing Adults is a clinical trial registered under NCT07489807. Current status: RECRUITING.

What is the status of NCT07489807?

The current status of NCT07489807 (The Effect of Mild-gain Amplification on Tinnitus Perception in Normal Hearing Adults) is: RECRUITING.

When did The Effect of Mild-gain Amplification on Tinnitus Perception in Normal Hearing Adults start?

The Effect of Mild-gain Amplification on Tinnitus Perception in Normal Hearing Adults started on 2025-04-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.